Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
MarsBio is an early-stage biotechnology investment fund based in the United States. Founded to support scientists and engineers, the firm focuses on building impactful businesses in the biotech sector. They invest in various areas, including synthetic biology and therapeutics.
MarsBio invests in pre-seed, seed, and seed+ (extension) stages within biotechnology. Their investment areas include synthetic biology, therapeutics, material science, agriculture, and consumer goods. The firm aims to back bold bioscience entrepreneurs at the earliest stages of their ventures.
MarsBio's portfolio features companies developing novel exosome immunotherapies, engineering implantable pockets for allogeneic cell therapies, and advancing single-cell sequencing for human immune system profiling. They also support innovations in remote health monitoring solutions, mitochondrial genome editing, engineered microbes for health applications, and technologies for producing drinkable water from atmospheric moisture.
Submit your pitch through their website's contact form for consideration.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.